(33) identified the significant upregulation of SPTBN2 expression in bladder cancer tumor samples compared with normal samples, and SPTBN2 expression was associated with a poor prognosis in bladder cancer. The gene discussed is SPTBN2; the disease is urinary bladder carcinoma.